Institutions / Employees Provident Fund Board / Activity
Activity — Employees Provident Fund Board
890 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q2 2018 as of | Add | Oracle Corp Common stock | $7.19M | +163K +14.19% | 1,313,786 0.43% of portfolio | medium |
| Q2 2021 as of | Add | Western Digital Corp Common stock | $7.19M | +101K +7.49% | 1,450,000 0.76% of portfolio | medium |
| Q4 2022 as of | Add | Salesforce Inc Common stock | $7.24M | +55K +21.85% | 304,440 0.30% of portfolio | medium |
| Q3 2022 as of | Add | Walt Disney Co Common stock | $7.25M | +77K +12813.17% | 77,479 0.05% of portfolio | medium |
| Q1 2025 as of | Add | Applied Materials Inc /De Common stock | $7.26M | +50K +5.90% | 896,781 0.96% of portfolio | medium |
| Q1 2025 as of | Add | Dexcom Inc Common stock | $7.31M | +107K +6.04% | 1,877,500 0.94% of portfolio | medium |
| Q4 2020 as of | Add | Pfizer Inc Common stock | $7.36M | +200K +5.57% | 3,789,108 1.03% of portfolio | medium |
| Q4 2022 as of | Add | 00507V109 Common stock | $7.37M | +96K +7.63% | 1,357,436 0.76% of portfolio | medium |
| Q4 2024 as of | Add | Cigna Group Common stock | $7.39M | +27K +91.54% | 56,000 0.11% of portfolio | medium |
| Q2 2025 as of | Add | The PNC Financial Services Group, Inc. Common stock | $7.40M | +40K +61.75% | 104,000 0.14% of portfolio | medium |
| Q4 2025 as of | Add | Micron Technology Inc Common stock | $7.40M | +26K +1.45% | 1,820,675 3.82% of portfolio | medium |
| Q4 2021 as of | Add | 067901108 Common stock | $7.45M | +391K +10.91% | 3,977,387 0.56% of portfolio | medium |
| Q2 2024 as of | Add | Intuitive Surgical Inc Common stock | $7.47M | +17K +10.63% | 174,701 0.57% of portfolio | medium |
| Q2 2022 as of | Add | Cummins Inc Common stock | $7.52M | +39K +52.15% | 113,375 0.16% of portfolio | medium |
| Q1 2023 as of | Add | Mastercard Inc Common stock | $7.58M | +21K +10.36% | 222,306 0.59% of portfolio | medium |
| Q1 2021 as of | Add | 81369Y506 Common stock | $7.60M | +155K +16.38% | 1,100,000 0.40% of portfolio | medium |
| Q2 2022 as of | Add | Biogen Inc. Common stock | $7.62M | +37K +10.52% | 392,680 0.59% of portfolio | medium |
| Q3 2023 as of | Add | Coca Cola Co Common stock | $7.63M | +136K +195.80% | 206,000 0.08% of portfolio | medium |
| Q1 2018 as of | Add | Oracle Corp Common stock | $7.66M | +168K +17.04% | 1,150,512 0.39% of portfolio | medium |
| Q3 2024 as of | Add | Estee Lauder Cos Inc/The Common stock | $7.70M | +77K +9.43% | 896,524 0.66% of portfolio | medium |
| Q2 2024 as of | Add | Mastercard Inc Common stock | $7.79M | +18K +9.77% | 198,500 0.64% of portfolio | medium |
| Q4 2024 as of | Add | Mastercard Inc Common stock | $7.90M | +15K +8.82% | 185,000 0.72% of portfolio | medium |
| Q2 2025 as of | Add | Stryker Corp Common stock | $7.99M | +20K +21.64% | 113,560 0.33% of portfolio | medium |
| Q2 2025 as of | Add | Amgen Inc Common stock | $8.02M | +29K +57.19% | 78,907 0.16% of portfolio | medium |
| Q1 2025 as of | Add | Equifax Inc Common stock | $8.03M | +33K +73.63% | 77,700 0.14% of portfolio | medium |
| Q3 2023 as of | Add | Estee Lauder Cos Inc/The Common stock | $8.17M | +57K +9.49% | 652,160 0.69% of portfolio | medium |
| Q4 2019 as of | Add | Alphabet Inc. Common stock | $8.21M | +6K +4.90% | 131,250 1.29% of portfolio | medium |
| Q3 2022 as of | Add | NIKE, Inc. Common stock | $8.41M | +101K +21.05% | 581,754 0.36% of portfolio | medium |
| Q4 2023 as of | Add | Dexcom Inc Common stock | $8.46M | +68K +7.44% | 985,048 0.90% of portfolio | medium |
| Q3 2021 as of | Add | Merck & Co., Inc. Common stock | $8.48M | +113K +4.50% | 2,623,328 1.45% of portfolio | medium |
| Q2 2017 as of | Add | Newmont Corp Common stock | $8.63M | +267K +18.75% | 1,687,826 0.40% of portfolio | medium |
| Q3 2017 as of | Add | 891160509 Common stock | $8.68M | +124K +13.72% | 1,023,813 0.53% of portfolio | medium |
| Q4 2020 as of | Add | Moody's Corp Common stock | $8.71M | +30K +78.79% | 68,065 0.15% of portfolio | medium |
| Q3 2022 as of | Add | Moody's Corp Common stock | $8.71M | +36K +19.42% | 220,193 0.39% of portfolio | medium |
| Q1 2018 as of | Add | Newmont Corp Common stock | $8.73M | +224K +39.26% | 792,807 0.23% of portfolio | medium |
| Q4 2025 as of | Add | Trane Technologies plc Common stock | $8.76M | +23K +84.91% | 49,000 0.14% of portfolio | medium |
| Q1 2024 as of | Add | Clorox Co /De Common stock | $8.78M | +57K +11.46% | 557,707 0.63% of portfolio | medium |
| Q1 2021 as of | Add | Pfizer Inc Common stock | $8.82M | +243K +6.42% | 4,032,509 1.07% of portfolio | medium |
| Q4 2023 as of | Add | Intuitive Surgical Inc Common stock | $8.83M | +26K +18.17% | 170,160 0.42% of portfolio | medium |
| Q2 2018 as of | Add | Meta Platforms Inc Common stock | $8.86M | +46K +6.54% | 743,075 1.06% of portfolio | medium |
| Q4 2022 as of | Add | NIKE, Inc. Common stock | $8.89M | +76K +13.07% | 657,764 0.57% of portfolio | medium |
| Q3 2022 as of | Add | 03662Q105 Common stock | $8.94M | +40K +40.94% | 138,811 0.23% of portfolio | medium |
| Q2 2018 as of | Add | Intel Corp Common stock | $8.94M | +180K +21.22% | 1,027,326 0.38% of portfolio | medium |
| Q4 2019 as of | Add | Cisco Systems, Inc. Common stock | $8.96M | +187K +6.97% | 2,867,757 1.01% of portfolio | medium |
| Q4 2018 as of | Add | 867224107 Common stock | $8.96M | +235K +20.93% | 1,358,437 0.38% of portfolio | medium |
| Q3 2017 as of | Add | Intel Corp Common stock | $9.01M | +237K +12.45% | 2,138,266 0.60% of portfolio | medium |
| Q2 2024 as of | Add | 42809H107 Common stock | $9.03M | +61K +19.74% | 371,432 0.40% of portfolio | medium |
| Q2 2017 as of | Add | 780087102 Common stock | $9.17M | +97K +18.55% | 622,685 0.43% of portfolio | medium |
| Q4 2017 as of | Add | 29250N105 Common stock | $9.19M | +187K +21.66% | 1,050,139 0.38% of portfolio | medium |
| Q4 2025 as of | Add | Moody's Corp Common stock | $9.21M | +18K +6.39% | 300,000 1.13% of portfolio | medium |